Findings demonstrated that DLGAP1-AS2 was significantly up-regulated in gastric cancer (GC) and its high expression was associated with poor prognosis, suggesting that DLGAP1-AS2 might be a putative oncogenic lncRNA of GC. Loss of DLGAP1-AS2 restricted cell proliferation, migration, and invasion in GC cell lines.
[Cell Death Discovery]